TORONTO, ONTARIO--(Marketwire - June 02, 2010) - Attention: Business/Financial Editors
The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE: MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, announced that on May 26, 2010, in accordance with its stock option plan and subject to regulatory approval, the board of directors of Medipattern has approved the grant of an aggregate of 1,750,000 incentive stock options to certain of its directors, officers, employees and consultants. The options are exercisable on or before May 26, 2015 at an exercise price of $0.10 per share, with a portion of the options granted subject to vesting at the rate of one-third of the options in one-year increments over a three-year period.
About The Medipattern Corporation
Medipattern® is a pioneer in the development of medical software solutions that help improve imaging workflow and productivity. Our first-to-market, award-winning B-CAD® advances breast ultrasound computer aided detection (CAD) by streamlining workflow and organizing information into a comprehensive patient record. Medipattern uses its Cadenza™ CAD Technology to power the digital conversion in medical communications. B-CAD automatically creates fully digital standardized worksheets and reports that make every practice more efficient, productive and ultimately more effective. For more information, please visit the Company's website at: www.medipattern.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.